The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
ATC code M: Musculo-skeletal system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.
Muscolo - Skeletal System
Tablets – 100 mg
Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).
Alopurin is indicated:
Adults
Tablets - 300mg
Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).
Alopurin is indicated:
Adults
Granules for oral suspension - 100 mg
Cox-in contains the active substance nimesulide. It belongs to a group of medicines called non-steroidal antiinflammatory drugs (NSAIDs) and has analgesic properties.
Cox-in is used for the treatment of acute pain and menstrual pain.
Nimesulide should only be prescribed as second-line treatment.
Solution for injection - 160 mg / 2 ml
Dolomed contains the active substance ketoprofen lysine.
Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory drug (NSAID).
Dolomed is indicated in:
the management of pain after orthopaedic surgery.
Suppositories - 100 mg
Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.
Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).
Durilac is used:
Solution for injection - 75 mg / 3 ml
Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.
Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).
Durilac is used:
Gel - 1%
Durilac contains the active substance diclofenac sodium, which is a non-steroidal anti-inflammatory drug (NSAID). Its action is based in the inhibition of cyclooxygenases, which participate in the biosynthesis of prostaglandins. Prostaglandins have an important role in the process of pain, inflammation and chills. Non - steroidal anti-inflammatory drugs inhibit cyclooxygenases-1 and-2 (COX-1 and-2). Inhibition of COX-1 is associated with gastrointestinal side effects, while the inhibition of COX-2 is associated with anti-inflammatory action.
Diclofenac is rapidly absorbed when it is given in the form of rectal suppositories or intramuscular injection. Diclofenac is also absorbed percutaneously. Approximately 99 % of the drug is bound with the plasma proteins. Diclofenac passes in the synovial fluid and in the breast milk. Its plasmatic half life is 1 – 2 hours. It is excreted in the form of glucuronides and sulphates, mainly through urine (65 %) and bile (35 %).
Durilac is used:
Granules for oral solution - 40 mg
Granules for oral solution
Suppositories – 75 mg
Suppositories – 150 mg
Film coated tablets - 400 mg
Film coated tablets - 400 mg
Film coated tablets - 600 mg
Oral suspension - 100 mg / 5 ml
Tablets - 0.5 mg
Oral drops solution – (10.000 UI + 10.000 UI) / ml
Tablets - 5 mg
Solution for injection - ( 0.1%) 1 mg/1 ml
Adrenaline is an endogenous substance that is produced in the adrenal medulla and has important physiological effects. It is a potent agonist at both alpha and beta adrenoceptors, although the effect on beta adrenoceptors is more marked, particularly at lower doses.
The major effects of adrenaline are dose-related and include:
dilatation of the bronchi, narrowing of blood vessels, increased heart rate and contractility (positive chronotropic and inotropic effect) and stimulation at central level. Adrenaline is a histamine antagonist. It is used for the treatment of life emergencies.
Adrenaline is used in acute allergic reactions and anaphylactic shock.
It is also used in advanced cardiac life support.
Cream - (4000 I.U.+2000 I.U.+2 mg+50 mg)/g
